For example, a meta-analysis including randomized clinical trials for atrial fibrillation or venous thromboembolism reported that apixaban showed a trend with an increased IOHs event rate compared to warfarin ( 5 ).
← all excerpts
Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database.
1
—
—